Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Baxter
Express Scripts
Merck
AstraZeneca

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR BEPREVE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Bepreve

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00424398 ↗ Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis Completed Bausch & Lomb Incorporated Phase 2/Phase 3 2007-02-01 The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis
NCT00586625 ↗ Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers Completed Bausch & Lomb Incorporated Phase 3 2007-10-01 Safety study for bepotastine besilate ophthalmic solution in normal volunteers
NCT01128556 ↗ The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing Completed North Texas Institute for Clinical Trials Phase 4 2010-04-01 To evaluate the effect of BEPREVE compared to a REFRESH Tears Lubricant eye drop on the measurement of the wheal and flare from histamine skin prick testing. This is an open label, two-week, post-marketing study conducted on histamine responsive patients.
NCT01337557 ↗ Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses Unknown status Bausch & Lomb Incorporated Phase 4 2011-05-01 The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.
NCT01337557 ↗ Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses Unknown status Hom, Milton M., OD, FAAO Phase 4 2011-05-01 The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.
NCT01346371 ↗ The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer Completed Bausch & Lomb Incorporated Phase 4 2011-05-01 The purpose of this study is to compare the effect of BepreveĀ® with an artificial-tear eye drop on the quality of your tears.
NCT01346371 ↗ The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer Completed Minnesota Eye Consultants, P.A. Phase 4 2011-05-01 The purpose of this study is to compare the effect of BepreveĀ® with an artificial-tear eye drop on the quality of your tears.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Bepreve

Condition Name

Condition Name for Bepreve
Intervention Trials
Allergic Conjunctivitis 4
Histamine Responsive Allergy Patients 1
Conjunctivitis, Allergic 1
Eye Allergies 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Bepreve
Intervention Trials
Conjunctivitis, Allergic 5
Conjunctivitis 5
Hypersensitivity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Bepreve

Trials by Country

Trials by Country for Bepreve
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Bepreve
Location Trials
California 2
Tennessee 1
Minnesota 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Bepreve

Clinical Trial Phase

Clinical Trial Phase for Bepreve
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Bepreve
Clinical Trial Phase Trials
Completed 6
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Bepreve

Sponsor Name

Sponsor Name for Bepreve
Sponsor Trials
Bausch & Lomb Incorporated 4
Hom, Milton M., OD, FAAO 1
Minnesota Eye Consultants, P.A. 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Bepreve
Sponsor Trials
Other 5
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Dow
Colorcon
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.